| RS2491193245 |
ARFGEF1
|
Health Risk |
Pathogenic |
— |
| RS2491199196 |
ADAMTS13
|
Health Risk |
Pathogenic |
— |
| RS2491201847 |
INVS
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2491202052 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2491206880 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491207258 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491207289 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491207478 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491207553 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491207743 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491207996 |
GABBR2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 59 |
| RS2491208206 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491208697 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491209605 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS2491209728 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS2491210783 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS2491211300 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS2491212714 |
ADAMTS13
|
Health Risk |
Likely pathogenic |
— |
| RS2491213298 |
MUSK
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 9, Congenital myasthenic syndrome 9 |
| RS2491219604 |
ADAMTS13
|
Health Risk |
Likely pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS2491229815 |
LARP4B
|
Health Risk |
Likely pathogenic |
Myoepithelial tumor, Myoepithelial tumor |
| RS2491236071 |
CAMSAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
CAMSAP1-related neuronal migration disorder, CAMSAP1-related neuronal migration disorder |
| RS2491236702 |
INVS
|
Health Risk |
Likely pathogenic |
Infantile nephronophthisis, Infantile nephronophthisis |
| RS2491240183 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2491240602 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2491244807 |
INVS
|
Health Risk |
Pathogenic |
Infantile nephronophthisis, Infantile nephronophthisis |
| RS2491245262 |
INVS
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2491256806 |
INVS
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2491257149 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2491263069 |
CAMSAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
CAMSAP1-related neuronal migration disorder, Cortical dysplasia |
| RS2491263327 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2491264758 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2491269542 |
CAMSAP1
|
Health Risk |
Likely pathogenic |
CAMSAP1-related neuronal migration disorder, Cortical dysplasia |
| RS2491289899 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491289979 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491301318 |
ARFGEF1
|
Health Risk |
Pathogenic |
— |
| RS2491339937 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2491340979 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2491349636 |
ADAMTS13
|
Health Risk |
Pathogenic |
Thrombotic thrombocytopenic purpura, Thrombotic thrombocytopenic purpura |
| RS2491362699 |
ARFGEF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2491362882 |
ARFGEF1
|
Health Risk |
Pathogenic |
Developmental delay, impaired speech |
| RS2491365757 |
ARFGEF1
|
Health Risk |
Likely pathogenic |
ARFGEF1-related disorder, ARFGEF1-related disorder |
| RS2491384447 |
PDCD6IP
|
Health Risk |
Pathogenic |
Microcephaly 29, primary |
| RS2491390525 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2491397213 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2491399852 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2491405260 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2491414715 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2491434471 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS2491447626 |
ARFGEF1
|
Health Risk |
Pathogenic |
— |
| RS2491448044 |
ARFGEF1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2491448473 |
ARFGEF1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2491449631 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2491450507 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2491459864 |
GATA3
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2491460045 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2491460705 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2491461227 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2491461355 |
GATA3
|
Health Risk |
Pathogenic |
Deafness, autosomal dominant |
| RS2491461857 |
GATA3
|
Health Risk |
Likely pathogenic |
GATA3-related disorder, GATA3-related disorder |
| RS2491462423 |
GATA3
|
Health Risk |
Pathogenic |
Hypoparathyroidism, deafness |
| RS2491463738 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2491464339 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2491464614 |
ARFGEF1
|
Health Risk |
Pathogenic |
Developmental delay, impaired speech |
| RS2491464754 |
GATA3
|
Health Risk |
Likely pathogenic |
Hypoparathyroidism, deafness |
| RS2491464855 |
GATA3
|
Health Risk |
Pathogenic |
— |
| RS2491465476 |
ARFGEF1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2491465612 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491466419 |
GATA3
|
Health Risk |
Likely pathogenic |
Hypoparathyroidism, deafness |
| RS2491470714 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491475182 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491477380 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491477929 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome type 1 |
| RS2491483344 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491483375 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491483952 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491484177 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491484187 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491484424 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491484630 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491484645 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491484828 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491484950 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2491485235 |
GATA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoparathyroidism, deafness |
| RS2491485930 |
GATA3
|
Health Risk |
Likely pathogenic |
Hypoparathyroidism, deafness |
| RS2491491847 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491491951 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491492247 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491492843 |
ABCA2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with poor growth and with or without seizures or ataxia, Intellectual developmental disorder with poor growth and with or without seizures or ataxia |
| RS2491494919 |
DHTKD1
|
Health Risk |
Likely pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491496929 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491500575 |
ABCA2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with poor growth and with or without seizures or ataxia, Intellectual developmental disorder with poor growth and with or without seizures or ataxia |
| RS2491503781 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491510569 |
CUBN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome type 1 |
| RS2491513673 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2491523011 |
WHRN
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2D, Usher syndrome type 2D |
| RS2491523324 |
WHRN
|
Health Risk |
Pathogenic |
— |
| RS2491529211 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS2491530582 |
WHRN
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2491536548 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |